M&A Deal Summary

Agno Pharma Acquires Particle Sciences

On December 18, 2023, Agno Pharma acquired life science company Particle Sciences from The Lubrizol

Acquisition Highlights
  • This is Agno Pharma’s 1st transaction in the Life Science sector.
  • This is Agno Pharma’s 1st transaction in the United States.
  • This is Agno Pharma’s 1st transaction in Pennsylvania.

M&A Deal Summary

Date 2023-12-18
Target Particle Sciences
Sector Life Science
Buyer(s) Agno Pharma
Sellers(s) The Lubrizol
Deal Type Divestiture

Target

Particle Sciences

Bethlehem, Pennsylvania, United States
Particle Sciences is a developer of complex formulations including drug eluting device product development as well as sterile and particulate drug products. Particle Sciences is based in Bethlehem, Pennsylvania.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Agno Pharma

New York, New York, United States

Category Company
Founded 2004
Sector Life Science
DESCRIPTION

Agno Pharma is a global small molecule CDMO supplying critical intermediates, active pharmaceutical ingredients (APIs), highly potent APIs, sterile APIs, and sterile drug product formulations to large and medium-sized pharmaceutical, biotech and CDMO customers. Agno Pharma was formed in 2004 and is based in New York, New York.


DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
State: Pennsylvania M&A 1 of 1
Country: United States M&A 1 of 1
Year: 2023 M&A 1 of 1

Seller(S) 1

SELLER

The Lubrizol

Wickliffe, Ohio, United States

Category Company
Founded 1928
Sector Chemicals
Employees7,000
Revenue 5.4B USD (2010)
DESCRIPTION

The Lubrizol Corporation is a specialty chemical company that produces and supplies technologies to customers in the global transportation, industrial and consumer markets. These technologies include lubricant additives for engine oils, other transportation-related fluids and industrial lubricants, as well as fuel additives for gasoline and diesel fuel. In addition, Lubrizol makes ingredients and additives for personal care products and pharmaceuticals; specialty materials, including plastics technology and performance coatings in the form of specialty resins and additives.


DEAL STATS #
Overall 4 of 4
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 4 of 4
State: Pennsylvania M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2023 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2023-10-04 Lubrizol - Warwick Chemical Mostyn Site

Wales, United Kingdom

Lubrizol's Warwick Chemical Mostyn Site produces stain removal ingredients for detergent products, features a robust infrastructure ideally suited for various chemical applications. Lubrizol's Warwick Chemical Mostyn Site is based in Wales, United Kingdom.

Sell -